• Noxafil use up by more than 20% per year in hospitalized children

    5 monthes ago - By Healio

    Noxafil use in hospitalized children increased significantly over a 10-year period, according to a study published in the Journal of the Pediatric Infectious Diseases Society. Most children who received the drug were aged younger than 13 years, researchers said.
    Noxafil , a second-generation triazole with antifungal activity against yeasts and molds, is approved as prophylaxis against invasive Aspergillus and Candida species infections in severely immunocompromised patients aged 13 years and older. The drug is also used to treat oropharyngeal candidiasis refractory to
    Read more ...